Protein Phosphatase-1 regulates Rift Valley fever virus replication

Alan Baer, Nazly Shafagati, Ashwini Benedict, Tatiana Ammosova, Andrey Ivanov, Ramin M. Hakami, Kaori Terasaki, Shinji Makino, Sergei Nekhai, Kylene Kehn-Hall

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Rift Valley fever virus (RVFV), genus Phlebovirus family Bunyaviridae, is an arthropod-borne virus endemic throughout sub-Saharan Africa. Recent outbreaks have resulted in cyclic epidemics with an increasing geographic footprint, devastating both livestock and human populations. Despite being recognized as an emerging threat, relatively little is known about the virulence mechanisms and host interactions of RVFV. To date there are no FDA approved therapeutics or vaccines for RVF and there is an urgent need for their development. The Ser/Thr protein phosphatase 1 (PP1) has previously been shown to play a significant role in the replication of several viruses. Here we demonstrate for the first time that PP1 plays a prominent role in RVFV replication early on during the viral life cycle. Both siRNA knockdown of PP1α and a novel PP1-targeting small molecule compound 1E7-03, resulted in decreased viral titers across several cell lines. Deregulation of PP1 was found to inhibit viral RNA production, potentially through the disruption of viral RNA transcript/protein interactions, and indicates a potential link between PP1α and the viral L polymerase and nucleoprotein. These results indicate that PP1 activity is important for RVFV replication early on during the viral life cycle and may prove an attractive therapeutic target.

Original languageEnglish (US)
Pages (from-to)79-89
Number of pages11
JournalAntiviral Research
Volume127
DOIs
StatePublished - Mar 1 2016

Fingerprint

Rift Valley fever virus
Protein Phosphatase 1
Virus Replication
Viral RNA
Life Cycle Stages
Phlebovirus
Bunyaviridae
Arboviruses
Nucleoproteins
Africa South of the Sahara
Livestock
Small Interfering RNA
Disease Outbreaks
Virulence
Vaccines
Cell Line

Keywords

  • Antiviral agent
  • Bunyaviridae
  • L polymerase
  • Phosphorylation
  • Protein phosphatase 1
  • Rift valley fever virus

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Baer, A., Shafagati, N., Benedict, A., Ammosova, T., Ivanov, A., Hakami, R. M., ... Kehn-Hall, K. (2016). Protein Phosphatase-1 regulates Rift Valley fever virus replication. Antiviral Research, 127, 79-89. https://doi.org/10.1016/j.antiviral.2016.01.007

Protein Phosphatase-1 regulates Rift Valley fever virus replication. / Baer, Alan; Shafagati, Nazly; Benedict, Ashwini; Ammosova, Tatiana; Ivanov, Andrey; Hakami, Ramin M.; Terasaki, Kaori; Makino, Shinji; Nekhai, Sergei; Kehn-Hall, Kylene.

In: Antiviral Research, Vol. 127, 01.03.2016, p. 79-89.

Research output: Contribution to journalArticle

Baer, A, Shafagati, N, Benedict, A, Ammosova, T, Ivanov, A, Hakami, RM, Terasaki, K, Makino, S, Nekhai, S & Kehn-Hall, K 2016, 'Protein Phosphatase-1 regulates Rift Valley fever virus replication', Antiviral Research, vol. 127, pp. 79-89. https://doi.org/10.1016/j.antiviral.2016.01.007
Baer A, Shafagati N, Benedict A, Ammosova T, Ivanov A, Hakami RM et al. Protein Phosphatase-1 regulates Rift Valley fever virus replication. Antiviral Research. 2016 Mar 1;127:79-89. https://doi.org/10.1016/j.antiviral.2016.01.007
Baer, Alan ; Shafagati, Nazly ; Benedict, Ashwini ; Ammosova, Tatiana ; Ivanov, Andrey ; Hakami, Ramin M. ; Terasaki, Kaori ; Makino, Shinji ; Nekhai, Sergei ; Kehn-Hall, Kylene. / Protein Phosphatase-1 regulates Rift Valley fever virus replication. In: Antiviral Research. 2016 ; Vol. 127. pp. 79-89.
@article{7e59359821f9471b8d64d38fbfffdbcb,
title = "Protein Phosphatase-1 regulates Rift Valley fever virus replication",
abstract = "Rift Valley fever virus (RVFV), genus Phlebovirus family Bunyaviridae, is an arthropod-borne virus endemic throughout sub-Saharan Africa. Recent outbreaks have resulted in cyclic epidemics with an increasing geographic footprint, devastating both livestock and human populations. Despite being recognized as an emerging threat, relatively little is known about the virulence mechanisms and host interactions of RVFV. To date there are no FDA approved therapeutics or vaccines for RVF and there is an urgent need for their development. The Ser/Thr protein phosphatase 1 (PP1) has previously been shown to play a significant role in the replication of several viruses. Here we demonstrate for the first time that PP1 plays a prominent role in RVFV replication early on during the viral life cycle. Both siRNA knockdown of PP1α and a novel PP1-targeting small molecule compound 1E7-03, resulted in decreased viral titers across several cell lines. Deregulation of PP1 was found to inhibit viral RNA production, potentially through the disruption of viral RNA transcript/protein interactions, and indicates a potential link between PP1α and the viral L polymerase and nucleoprotein. These results indicate that PP1 activity is important for RVFV replication early on during the viral life cycle and may prove an attractive therapeutic target.",
keywords = "Antiviral agent, Bunyaviridae, L polymerase, Phosphorylation, Protein phosphatase 1, Rift valley fever virus",
author = "Alan Baer and Nazly Shafagati and Ashwini Benedict and Tatiana Ammosova and Andrey Ivanov and Hakami, {Ramin M.} and Kaori Terasaki and Shinji Makino and Sergei Nekhai and Kylene Kehn-Hall",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.antiviral.2016.01.007",
language = "English (US)",
volume = "127",
pages = "79--89",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",

}

TY - JOUR

T1 - Protein Phosphatase-1 regulates Rift Valley fever virus replication

AU - Baer, Alan

AU - Shafagati, Nazly

AU - Benedict, Ashwini

AU - Ammosova, Tatiana

AU - Ivanov, Andrey

AU - Hakami, Ramin M.

AU - Terasaki, Kaori

AU - Makino, Shinji

AU - Nekhai, Sergei

AU - Kehn-Hall, Kylene

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Rift Valley fever virus (RVFV), genus Phlebovirus family Bunyaviridae, is an arthropod-borne virus endemic throughout sub-Saharan Africa. Recent outbreaks have resulted in cyclic epidemics with an increasing geographic footprint, devastating both livestock and human populations. Despite being recognized as an emerging threat, relatively little is known about the virulence mechanisms and host interactions of RVFV. To date there are no FDA approved therapeutics or vaccines for RVF and there is an urgent need for their development. The Ser/Thr protein phosphatase 1 (PP1) has previously been shown to play a significant role in the replication of several viruses. Here we demonstrate for the first time that PP1 plays a prominent role in RVFV replication early on during the viral life cycle. Both siRNA knockdown of PP1α and a novel PP1-targeting small molecule compound 1E7-03, resulted in decreased viral titers across several cell lines. Deregulation of PP1 was found to inhibit viral RNA production, potentially through the disruption of viral RNA transcript/protein interactions, and indicates a potential link between PP1α and the viral L polymerase and nucleoprotein. These results indicate that PP1 activity is important for RVFV replication early on during the viral life cycle and may prove an attractive therapeutic target.

AB - Rift Valley fever virus (RVFV), genus Phlebovirus family Bunyaviridae, is an arthropod-borne virus endemic throughout sub-Saharan Africa. Recent outbreaks have resulted in cyclic epidemics with an increasing geographic footprint, devastating both livestock and human populations. Despite being recognized as an emerging threat, relatively little is known about the virulence mechanisms and host interactions of RVFV. To date there are no FDA approved therapeutics or vaccines for RVF and there is an urgent need for their development. The Ser/Thr protein phosphatase 1 (PP1) has previously been shown to play a significant role in the replication of several viruses. Here we demonstrate for the first time that PP1 plays a prominent role in RVFV replication early on during the viral life cycle. Both siRNA knockdown of PP1α and a novel PP1-targeting small molecule compound 1E7-03, resulted in decreased viral titers across several cell lines. Deregulation of PP1 was found to inhibit viral RNA production, potentially through the disruption of viral RNA transcript/protein interactions, and indicates a potential link between PP1α and the viral L polymerase and nucleoprotein. These results indicate that PP1 activity is important for RVFV replication early on during the viral life cycle and may prove an attractive therapeutic target.

KW - Antiviral agent

KW - Bunyaviridae

KW - L polymerase

KW - Phosphorylation

KW - Protein phosphatase 1

KW - Rift valley fever virus

UR - http://www.scopus.com/inward/record.url?scp=84956883878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956883878&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2016.01.007

DO - 10.1016/j.antiviral.2016.01.007

M3 - Article

C2 - 26801627

AN - SCOPUS:84956883878

VL - 127

SP - 79

EP - 89

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

ER -